110 related articles for article (PubMed ID: 9165132)
1. Hyperfractionation: where do we stand?
Beck-Bornholdt HP; Dubben HH; Liertz-Petersen C; Willers H
Radiother Oncol; 1997 Apr; 43(1):1-21. PubMed ID: 9165132
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials.
Stuschke M; Thames HD
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):259-67. PubMed ID: 9069295
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic gain factor of multiple fractions per day].
Kanehira C; Mochizuki S
Gan No Rinsho; 1988 Oct; 34(13):1757-63. PubMed ID: 3199511
[TBL] [Abstract][Full Text] [Related]
4. [Altered fractionation].
Hasegawa M; Nishio M; Myoujin M; Nishiyama N; Ichimura W
Gan To Kagaku Ryoho; 2006 Apr; 33(4):428-35. PubMed ID: 16612149
[TBL] [Abstract][Full Text] [Related]
5. [Prospective randomized trials comparing hyperfractionated radiotherapy with conventional radiotherapy in stage III non-small cell lung cancer].
Kagami Y; Nishio M; Narimatsu N; Ogawa H; Sakurai T
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Oct; 52(10):1452-5. PubMed ID: 1333071
[TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer and CHART (continuous hyperfractionated accelerated radiotherapy)--where do we stand?
Eakin RL; Saunders MI
Ulster Med J; 2000 Nov; 69(2):128-36. PubMed ID: 11196724
[TBL] [Abstract][Full Text] [Related]
7. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee.
Saunders MI; Dische S; Barrett A; Parmar MK; Harvey A; Gibson D
Br J Cancer; 1996 Jun; 73(12):1455-62. PubMed ID: 8664112
[TBL] [Abstract][Full Text] [Related]
8. A new approach to dose escalation in non-small-cell lung cancer.
Mehta M; Scrimger R; Mackie R; Paliwal B; Chappell R; Fowler J
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):23-33. PubMed ID: 11163494
[TBL] [Abstract][Full Text] [Related]
9. Continuous hyperfractionated accelerated radiotherapy (CHART) and non-conventionally fractionated radiotherapy in the treatment of non-small cell lung cancer: a review and consideration of future directions.
Hatton MQ; Martin JE
Clin Oncol (R Coll Radiol); 2010 Jun; 22(5):356-64. PubMed ID: 20399629
[TBL] [Abstract][Full Text] [Related]
10. [The hyperfractionated radiotherapy of tumors in the head-neck area].
Dubben HH; Baumann M; Fassbender T; Beck-Bornholdt HP
Strahlenther Onkol; 1992 Jul; 168(7):373-82. PubMed ID: 1496447
[TBL] [Abstract][Full Text] [Related]
11. Altered radiotherapy fractionation: an opportunity not to be missed.
Benson RJ; Burnet NG
Clin Oncol (R Coll Radiol); 1998; 10(3):150-4. PubMed ID: 9704175
[No Abstract] [Full Text] [Related]
12. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
Brizel DM; Albers ME; Fisher SR; Scher RL; Richtsmeier WJ; Hars V; George SL; Huang AT; Prosnitz LR
N Engl J Med; 1998 Jun; 338(25):1798-804. PubMed ID: 9632446
[TBL] [Abstract][Full Text] [Related]
13. [Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
Natale D; Orlando D
Suppl Tumori; 2004; 3(4):S123-4. PubMed ID: 15206236
[No Abstract] [Full Text] [Related]
14. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase I study of standard-fractionated or accelerated-hyperfractionated radiotherapy with concurrent cisplatin and vindesine for unresectable non-small cell lung cancer: a report of Japan Clinical Oncology Group Study (JCOG 9601).
Tsuchiya S; Ohe Y; Sugiura T; Fuwa N; Kitamoto Y; Mori K; Kobayashi H; Nakata K; Sawa T; Hirai K; Etoh T; Saka H; Saito A; Fukuda H; Ishizuka N; Saijo N;
Jpn J Clin Oncol; 2001 Oct; 31(10):488-94. PubMed ID: 11696618
[TBL] [Abstract][Full Text] [Related]
16. Improved results with accelerated hyperfractionated radiotherapy of advanced head and neck cancer.
Leborgne F; Zubizarreta E; Fowler J; Ortega B; Mezzera J; Deus JL; Leborgne JH
Int J Cancer; 2000 Apr; 90(2):80-91. PubMed ID: 10814958
[TBL] [Abstract][Full Text] [Related]
17. Is double data entry necessary? The CHART trials. CHART Steering Committee. Continuous, Hyperfractionated, Accelerated Radiotherapy.
Gibson D; Harvey AJ; Everett V; Parmar MK
Control Clin Trials; 1994 Dec; 15(6):482-8. PubMed ID: 7851109
[TBL] [Abstract][Full Text] [Related]
18. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx, larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG).
Marcial VA; Pajak TF; Chang C; Tupchong L; Stetz J
Int J Radiat Oncol Biol Phys; 1987 Jan; 13(1):41-7. PubMed ID: 3542916
[TBL] [Abstract][Full Text] [Related]
19. [The state of the art: radiation therapy for non-small cell lung cancer].
Chatani M
Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():373-8. PubMed ID: 9369910
[TBL] [Abstract][Full Text] [Related]
20. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results.
King SC; Acker JC; Kussin PS; Marks LB; Weeks KJ; Leopold KA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):593-9. PubMed ID: 8948343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
